Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Paris
Clinical trial register · France

Clinical Trials in Paris, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9722 matching records held by the registry are in this view. Synced 29 Oct 2026, 03:20 UTC
9722
Studies in scope
all four open statuses
6047
Recruiting now
open to new participants
1031
Lead sponsors
across recruiting studies
Top sites
Paris 36 Marseille 24 Lille 23 Montpellier 22 Villejuif 21
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Assistance Publique - Hôpitaux de Paris604 Novartis Pharmaceuticals68 Fondation Ophtalmologique Adolphe de Rothschild67 Institut National de la Santé Et de la Recherche Médicale, France64 AstraZeneca64 Clear sponsor filter
Site location
Paris36 Marseille24 Lille23 Montpellier22 Villejuif21
All 65 locations
Target enrolment
to

Trials with a site in Paris

36 of 9722 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Bristol-Myers Squibb
Phase 2
80
Rennes, Villejuif, Toulouse, Paris
2026-11-30
Not yet open
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
NCT07873931Systemic Lupus Erythematosus, Sjögren's Disease, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies
Bristol-Myers Squibb
Phase 1
60
Montpellier, Paris
2026-10-30
Not yet open
Bristol-Myers Squibb
Phase 3
176
Bordeaux, Bron, Paris
2026-10-02
Recruiting
Bristol-Myers Squibb
Phase 2
160
Nice, Montpellier, Villejuif, Grenoble, Marseille, Paris, Saint-Herblain
2026-09-10
Recruiting
Bristol-Myers Squibb
Phase 3
850
Marseille, Dijon, Nantes, La Tronche, Lyon, Paris, Bron, Villejuif
2026-09-08
Recruiting
Bristol-Myers Squibb
Phase 2
260
Dijon, Pierre-Bénite, Villejuif, Paris
2026-07-27
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Lyon Cedex08, Brest, Lille, Nantes, Poitiers, Marseille, Paris
2026-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
650
Toulouse, Villeurbanne, Lille, Limoges, Montpellier, Paris, Strasbourg
2025-12-02
Recruiting
Bristol-Myers Squibb
Phase 3
424
Nice, Clermont-Ferrand, Marseille, Montpellier, Paris
2025-10-08
Recruiting
Bristol-Myers Squibb
Observational
223
Bordeaux, Strasbourg, Paris
2025-10-08
Active, closed
Bristol-Myers Squibb
Phase 2
76
Dijon, Suresnes, Paris
2025-09-19
Recruiting
Bristol-Myers Squibb
Phase 2
182
La Tronche, Saint-Herblain, Vandœuvre-lès-Nancy, Bron, Paris
2025-09-09
Recruiting
Bristol-Myers Squibb
Phase 3
426
Toulouse, Villeurbanne, Lille, Limoges, Montpellier, Paris, Strasbourg
2025-07-16
Recruiting
Bristol-Myers Squibb
Phase 1/2
416
Nice, Bordeaux, Lyon, Marseille, Caen, Montpellier, Villejuif, Paris
2025-02-04
Active, closed
Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France
NCT06504615Gastric Adenocarcinoma, Gastro-esophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma (EAC), Esophageal Squamous Cell Carcinoma (ESCC)
DrugNivolumab
Bristol-Myers Squibb
Observational
208
Paris
2024-12-10
Recruiting
Bristol-Myers Squibb
Phase 1/2
224
Créteil, Marseille, Paris, Strasbourg
2024-07-17
Active, closed
Bristol-Myers Squibb
Phase 3
44
Paris, Pessac
2024-04-17
Recruiting
Bristol-Myers Squibb
Phase 1/2
460
Bordeaux, Lyon, Lille, Villejuif, Créteil, Montpellier, Paris, Toulouse
2023-12-29
Active, closed
Bristol-Myers Squibb
Phase 3
190
Strasbourg, Pessac, Dijon, Rouen, La Tronche, Saint-Herblain, Pierre-Bénite, Paris
2023-12-21
Active, closed
Bristol-Myers Squibb
Phase 3
402
Nice, Pessac, Tours, La Tronche, Vandœuvre-lès-Nancy, Angers, Villejuif, Paris
2023-10-24
Recruiting
Bristol-Myers Squibb
Phase 1
140
Bordeaux, Lyon Cedex08, Marseille, Villejuif, Paris
2023-10-18
Active, closed
Bristol-Myers Squibb
Phase 3
106
Nice, Poitiers, Angers, Grenoble, Paris, Pierre-Bénite, Tour Cedex01
2023-10-05
Active, closed
Bristol-Myers Squibb
Phase 3
774
Amiens, Bordeaux, Grenoble, Le Havre, Le Kremlin-Bictre, Paris
2023-09-11
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Amiens, Caen, Créteil, La Roche-sur-Yon, Lille, Limoges, Nantes, Paris
2023-06-22
Active, closed
Bristol-Myers Squibb
Phase 2/3
230
Pessac, Tours, Angers, Lille, Villejuif, Paris
2022-12-14
Active, closed
Bristol-Myers Squibb
Observational
350
Paris
2022-07-29
Recruiting
Bristol-Myers Squibb
Phase 2/3
120
Toulouse, Bron, Caen, Paris
2022-05-30
Recruiting
Bristol-Myers Squibb
Phase 3
102
Nantes, Bordeaux, Bron, Marseille, Paris
2021-07-21
Active, closed
Bristol-Myers Squibb
Phase 3
670
Chambray-lès-Tours, Montpellier, Paris
2021-07-13
Active, closed
Bristol-Myers Squibb
Phase 2
74
Bordeaux, Créteil, Paris
2021-07-12
Recruiting
Bristol-Myers Squibb
Phase 3
153
Calais, Dijon, Nice, Paris
2021-03-23
Active, closed
Bristol-Myers Squibb
Phase 1/2
216
Brest, Marseille, Nice, Paris, Villejuif
2021-03-22
Active, closed
Bristol-Myers Squibb
Phase 3
461
Besançon, La Tronche, Montpellier, Paris, Rennes, Rouen
2019-11-05
Active, closed
Bristol-Myers Squibb
Phase 3
790
Brest, Besançon, Bordeaux, Lille, Marseille, Nantes, Nice, Paris
2019-10-28
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Rennes, Amiens, Bordeaux, Lille, Marseille, Paris, Pierre-Bénite, Poitiers
2018-04-11
Active, closed
Bristol-Myers Squibb
Observational
800
Clermont-Ferrand, Paris, Toulouse
2013-01-30
Rows per page Showing 1–36 of 36
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 30 October 2026. https://priyalifescience.com/clinical-trials-france/city/paris

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,722 studies in total at the last sync on 29 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 36 of those studies with a site in Paris that also match the filters currently applied.

How many clinical trials are recruiting in Paris?

16 of the 36 studies on this page are recruiting new participants as of the 29 Oct 2026, 03:20 UTC sync. A further 3 have not yet opened recruitment, 17 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Paris), 36 studies
PhaseStudiesRecruitingShare
Phase 316644.4%
Phase 26316.7%
Observational4111.1%
Phase 1/24311.1%
Phase 2/34211.1%
Phase 1215.6%

Most active sponsors

Lead sponsors with the most studies (Paris)
Lead sponsorStudiesRecruiting
Bristol-Myers Squibb3616
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.